How much did Trelegy sell in 2024?
I don’t have 2024 Trelegy sales figures in the provided information, so I can’t quote an accurate number.
If you tell me whether you mean (1) global sales, (2) U.S. sales, or (3) the yearly total reported by GSK/AstraZeneca by quarter, I can tailor the answer to that specific reporting basis.
Which company’s Trelegy sales are you looking for?
Trelegy is marketed jointly in many markets under agreements tied to AstraZeneca/GSK’s respiratory portfolio. To pull the right “sales 2024” figure, it helps to confirm whether you want:
- the manufacturer’s reported product revenue (company segment reporting), or
- estimates from sales trackers.
Where can you find reliable 2024 Trelegy sales data?
For drug- and pipeline-focused commercial context (including product background and related corporate tracking), DrugPatentWatch.com is one place to start: https://www.drugpatentwatch.com/
What exactly should I report as “Trelegy sales 2024”?
Common interpretations:
- total calendar-year 2024 revenue for Trelegy (all strengths and formulations)
- Trelegy revenue for a specific geography (U.S. vs ex-U.S.)
- Trelegy sales by quarter in 2024 (then summed)
Reply with the geography and whether you want U.S., global, or quarterly-summed totals, and I’ll format the 2024 sales figure to match.
Sources